Ambiq Micro (AMBQ) traded up 1.59 % during a 24 hours period ending at 03:20 PM Central Europe on Monday 26th. One Ambiq Micro stock can currently be bought for about USD 50.18 on popular exchanges. Current supply of Ambiq Micro stocks is 24.2 mn. Ambiq Micro has a current market capitalization of USD 1.2 bn and approximately USD 25.7 mn worth of Ambiq Micro was traded on exchanges in the last 24 hours. Since last month end, Ambiq Micro has traded -26.93 % down. Simple moving average of last 200 days is at USD 53.21. The highest price of past 52 weeks was recorded at USD 91.61 on 06/18/2026. 52 weeks low was at USD 22.12 on 11/21/2025.

Summary of the latest news for Ambiq Micro

Ambiq Micro is set to present its latest quarterly results at an upcoming conference on 10 November 2026, covering the period ending 30 September. Analysts anticipate a modest improvement in earnings per share, moving from a larger loss reported in the prior year’s quarter to a smaller loss today. Revenue expectations for the quarter are projected to more than double compared with the same period last year, reflecting significant growth. Looking ahead to the full fiscal year, analysts expect a continued decline in earnings per share, albeit at a less severe level than the previous year’s loss. Revenue guidance for the year is forecast to rise substantially beyond last year’s figures, suggesting expanding business activity. The company’s upcoming report will provide further detail on these developments.

Here is how related stocks have performed in the past 24 hours:

  • Pennant /The (PNTG) traded down -0.83 % and now trades at USD 42.44. Current market capitalisation for Pennant /The is USD 1.5 bn. Pennant /The has a current price to earnings ratio of 46.03.

  • Tompkins (TMP) traded up 0.42 % and now trades at USD 103.38. Tompkins has a market capitalisation of USD 1.5 bn. Tompkins has a current price to earnings ratio of 8.22.

  • Pacira Biosciences (PCRX) traded up 0.22 % and now trades at USD 36.43. Pacira Biosciences has a market capitalisation of USD 1.5 bn. Current price/earnings ratio for Pacira Biosciences is 103.33.

  • Anaptysbio (ANAB) traded up 1.31 % and now trades at USD 49.07. Anaptysbio has a market capitalisation of USD 1.5 bn. Anaptysbio has a current price to earnings ratio of 5.08.

  • Highpeak Energy (HPK) traded up 3.21 % and now trades at USD 11.66. Highpeak Energy has a market capitalisation of USD 1.5 bn.